Tenzing Acquisition Corp.
Status: Deal Closed
U=S+W
W=S@11.5
| IPO Proceeds, $M | $63.25M |
|---|---|
| IPO Date | Aug 21, 2018 |
| CEO | Rahul Nayar |
| Left Lead | Maxim |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 18+3+2+1+1+3 |
| IPO Sector |
General
India |
| IPO Geography | Asia |
| Target Company | Reviva Pharma |
| Deal Announced | Jul 21, 2020 |
| Deal Size, $M | $85.80M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings | www.sec.gov |
| Approval Vote | Dec 8, 2020 |
| Amendment Vote | TBD |
| Closing Date | Dec 14, 2020 |
Formerly TZAC
RVPH
RVPHW
| Price | $1.31 |
|---|---|
| Last closing price | $1.26 |
| H/L, today | $1.19 / $1.30 |
| H/L, 52-week | $3.04 / $9.25 |
| Volume, today | 252,396 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Tenzing Acquisition Corp.:
- Structure and cap table
- 7 directors & officers
- 43 filings and events
- 1 underwriters
- 1 deal advisors
- 3 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Parag Saxena | 63 | Chairman of the Board |
| Rahul Nayar | 49 | CEO & Director |
| Gonzalo Cordova | 63 | CFO |
| Atanuu Agarrwal | 29 | Vice President |
| William I. Campbell | 74 | Director |
| Nina Shapiro | 69 | Director |
| Vikas Thapar | 69 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| Maxim | BR | 5,500,000 | units |
| 5,500,000 | units | ||
| Up-Front UW fee | 2.25 | % | |
| Deferred UW fee |
3.50 | % |
Sign in to view more advisor data.
Deal
Sign in to view merger details and deal financials.